Clinical Trial

Medtronic Hugo™ Robotic Assisted Surgery (RAS) System in Urologic Surgery (Expand URO)

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study will evaluate the safety and performance of the Medtronic Hugo™ RAS System when used for urologic RAS procedures.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2023-01-23; most recent amendment 2025-11-13.
Status change: Withheld → Active, Not Recruiting 2025-04-17
Trial Details
NCT Number NCT05696444
Lead Sponsor Medtronic - MITG
Conditions Bladder Cancer, Prostate Cancer, Kidney Cancer, Pelvic Tumor, Interstitial Cystitis, Congenital Abnormalities, End Stage Renal Disease, Renal Tumor +1 more
Enrollment 144 participants
Start Date 2022-12-14
Primary Completion 2024-10-10 (estimated)
Study Completion 2030-01-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-25